Global Genital Warts Treatment Market, by Drug Type (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,628.9 million in 2021 and is expected to exhibit a CAGR of 4.7% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Increasing prevalence of sexually transmitted diseases (STDs) and Human Papilloma Virus (HPV) infection cases are expected to increase the growth of the global genital warts treatment market over the forecast period.
According to the article published in the Kaiser Family Foundation: 2020, there are an estimated 20 million new sexually transmitted infections (STIs) every year in the U.S. with rates of reported STIs continuing to rise
Global Genital Warts Treatment Market - Impact of Coronavirus (Covid-19) Pandemic
The coronavirus (COVID-19) pandemic and lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors, which is majorly impacted by the COVID 19 pandemic.
Coronavirus pandemic has negatively impacted the development, production, and supply of medicines and also affected growth of the pharmaceutical businesses of various companies across the globe, as COVID-19 pandemic has led to lockdown in several countries, globally. This lockdown has resulted in closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the pharmaceuticals and kits for diagnostic and therapeutic use.
Thus, COVID-19 pandemic has affected the economy in three main ways; 1) By directly affecting the production and demand; 2) By creating disruptions in distribution channels; and 3) By its financial impact on firms and financial markets.
Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to global lockdown, while many countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of pharmaceutical drugs from one place to another.
Browse 26 Market Data Tables and 28 Figures spread through 149 Pages and in-depth TOC on “Genital Warts Treatment Market”- Global Forecast to 2028, by Drug Type (Imiquimod, Podophyllin and Podofilox, Trichloroacetic Acid, Sinecatechins, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Global Genital Warts Treatment Market, click the link below:
Increasing number of product launches by key players is expected to drive the growth of the genital warts treatment market.
For instance, in June 2013, Teva Pharmaceuticals, a global pharmaceutical company, announced the launch and availability of imiquimod cream, which is a generic version of Medicis Pharmaceutical Corp.'s Aldara. The drug is used to treat external genital and rectal warts, certain types of actinic keratosis, and basal cell carcinoma.
Key Takeaways of the Global Genital Warts Treatment Market: